Latest Conference Articles

Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, talks about some memorable experiences he has had with burn patients.

Pharmacists should take advantage of the FDA's adverse drug event reporting system to promote patient safety.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the pharmacist's role in acute coronary syndrome management with platelet aggregation inhibitors.

Certain items are must-haves in any crash cart during a hospital code.

Natasha Nicol, Pharm D, FASHP, director of Global Patient Safety Affairs at Cardinal Health, discusses internal and external factors that could affect pharmacists' reliability.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses some ways pharmacists can help in cardiopulmonary resuscitation efforts.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, talks about what is inside a crash cart.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses the role pharmacists can play in emergency situations.

Andrew North, PharmD, BCPS, a specialty practice pharmacist in emergency medicine at the Ohio State University Wexner Medical Center, discusses what is in a crash cart beyond medications.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses the role of the pharmacist in ACS management with platelet aggregation inhibitors.

Patrick Dougherty, PharmD, BCPS, a clinical pharmacist at the Emergency Medicine Peninsula Regional Medical Center, discusses how pharmacists can help burn patients.

Health-system pharmacists can help save lives by reducing the risk of medication errors before, during, and after hospital emergency codes.

Should hospitals open their own medical marijuana dispensaries?

Matthew C. Grissinger, RPh, FISMP, FASCP, director, of error reporting programs at the Institute for Safe Medication Practices, discusses what the pharmacist's role is in managing the medication process outside the pharmacy.

The secrets to pharmacy success can be obtained by changing the way in which one views the pharmacy business.

Pharmacy Development Services (PDS), the leading provider of business education for independent pharmacy owners, has announced the ten recipients of the 2015 PDS Conference Showcase of Success. For the past nine years, the Showcase of Success segment has been an integral part of the annual business growth conference as a way to demonstrate the opportunities for real results in the industry.

Pharmacy Development Services has announced an exceptional line-up of professional keynote speakers for its 11th annual independent business growth conference in 2015. The PDS Conference will take place from February 18 " 21, 2015 at the Renaissance Hotel in Orlando, Florida.

Researchers at the American Epilepsy Society meeting reported important strides in the understanding of epilepsy, including identification of new therapeutic targets in the brain, as discussed by Esther Krook-Magnuson, PhD, as well as improved understanding of the factors involved in sudden death of patients with epilepsy, and a greater recognition of the benefits of neurosurgery in patients with epilepsy.

Several new antiepileptic drugs have recently been approved in the United States. In a symposium at the American Epilepsy Society in Seattle, Washington, Professor Martin J. Brodie, MD, director of the epilepsy unit of the Western Infirmary in Glasgow, Scotland, discussed some considerations with ezogabine and eslicarbazepine.

Mark Cook, MD, of the University of Melbourne, and Brian Litt, MD, of the Penn Epilepsy Center and the Center for Neuroengineering and Therapeutics at the University of Pennsylvania, discuss how new devices, big data, and massive online competitions are enabling prediction of seizures before they start.

S. L. Moshé, MD, of the Albert Einstein College of Medicine and Montefiore Medical Center, discusses the importance of creating disease-specific models of epilepsy in animal models for understanding and treating specific epilepsy subtypes.

The links between epilepsy and other diseases offer clues for early treatment. Frances E. Jensen, MD, past AES president and professor at Cornell Medical School, describes these links, and what they mean for future epilepsy treatment modalities.

Kristen Park, MD, assistant professor of pediatrics and neurology at the University of Colorado, discussed the potential risks and benefits of alternative therapies for epilepsy, including medical marijuana.

Treating patients with status epilepticus is a challenging balance of minimizing the risk of medication adverse events while managing the serious dangers of status epilepticus itself.

Antiepileptic medications are a broad category of drugs with many potential adverse events. In this session, Eugen Trinka, MD, MSc, reviews the most common adverse events associated with these therapies.

Understanding the recommendations of evidence-based guidelines is an important component of treating patients with therapies backed by the best available evidence.

Speakers at the ASHP Midyear Clinical Meeting ranging from ASHP President Gerald Meyer, PharmD, to Michael Lee, PharmD, of the Indian Health Service, argued that pharmacists are closer than ever before to achieving their goal of attaining provider status.

Specialty pharmacy presents itself as both a challenging business model and a significant financial opportunity under the right circumstances, especially for health systems. Kevin Colgan, MA, FASHP, of Rush University Medical Center and Kyle Skiermont, PharmD, of Fairview Pharmacy Services provided an overview of specialty pharmacies and presented strategies for building a successful specialty pharmacy business.